Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Surveillance after surgery for RCC is important because approximately 50% of these patients will develop a disease recurrence, two thirds of who will recur within the first year. Although the prognosis is generally poor in these patients, some may respond favorably to immunotherapy. The small subset of patients who develop solitary metastases has the greatest chance to achieve long-term survival. Aggressive surgical resection is an integral part of this success. Proposed surveillance protocols using a stage-based approach or an integrated approach combining stage with other important prognostic factors attempt to provide a rational approach to identifying treatable recurrences while minimizing unnecessary examinations and patient anxiety. However, strict adherence to follow-up guidelines may not be appropriate for all patients. Factors including patient comorbidities and patient willingness to pursue aggressive management in the event of recurrence may alter the follow-up for each individual.

[1]  M. Blute,et al.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. , 1996, The Journal of urology.

[2]  G. Giacco,et al.  Osseous metastases secondary to renal cell carcinoma. , 1981, Urology.

[3]  J. Dekernion,et al.  Treatment of advanced renal cell carcinoma--traditional methods and innovative approaches. , 1983, The Journal of urology.

[4]  C. Dinney,et al.  Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. , 1998, The Journal of urology.

[5]  Hiroshi Sato,et al.  Differences in the ability of cells to fuse are mediated by strains of epstein‐barr virus , 1989, The Laryngoscope.

[6]  E. Becht,et al.  Kidney preserving surgery in renal cell tumors: indications, techniques and results in 152 patients. , 1993, The Journal of urology.

[7]  I. Derweesh,et al.  Nephron-sparing surgery for renal cell carcinoma. , 2003, Cancer treatment and research.

[8]  M. Wichmann,et al.  Long-term results after pulmonary resection of renal cell carcinoma metastases. , 2002, The Annals of thoracic surgery.

[9]  C. Dinney,et al.  Therapy of locally recurrent renal cell carcinoma after nephrectomy. , 1996, The Journal of urology.

[10]  S. Campbell,et al.  Management of local recurrence following radical nephrectomy or partial nephrectomy. , 1994, The Urologic clinics of North America.

[11]  Alamdari,et al.  Follow‐up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy , 1999, BJU international.

[12]  R. Figlin,et al.  Renal and adrenal tumors : biology and management , 2002 .

[13]  T. Satoh,et al.  Distant metastasis of renal adenocarcinoma in nephrectomized cases. , 1982, The Journal of urology.

[14]  J. Wickham,et al.  Conservative Surgery of Renal Carcinoma: The EIRSS Experience , 1981 .

[15]  B. Delahunt,et al.  Histopathologic prognostic indicators for renal cell carcinoma. , 1998, Seminars in diagnostic pathology.

[16]  J. Kozlowski Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites. , 1994, The Urologic clinics of North America.

[17]  M. Resnick,et al.  A new protocol for the followup of renal cell carcinoma based on pathological stage. , 1995, The Journal of urology.

[18]  R. Figlin,et al.  Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.

[19]  J. Roland,et al.  Paradoxical spread of renal cell carcinoma to the head and neck , 1998, The Laryngoscope.

[20]  R. Colvin,et al.  Diagnosis and management of renal cell carcinoma A clinical and pathologic study of 309 cases , 1971, Cancer.

[21]  N. Goldstein,et al.  The current state of renal cell carcinoma grading , 1997, Cancer.

[22]  M. Blute,et al.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery , 1996 .

[23]  M. Makuuchi,et al.  Hepatectomy for metastatic renal cell carcinoma. , 1997, Hepato-gastroenterology.

[24]  R. Figlin,et al.  Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Thrasher,et al.  Prognostic factors in renal cancer. , 1993, The Urologic clinics of North America.

[26]  M. Burt,et al.  Resection of metastatic renal cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Belis,et al.  Computerized tomography in the early postoperative management of renal cell carcinoma. , 1986, The Journal of urology.

[28]  W. T. Farrington,et al.  Metastatic renal cell carcinoma to the nose and paranasal sinuses , 2000, Head & neck.

[29]  S. Campbell,et al.  Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. , 1997, The Journal of urology.

[30]  M. Blute,et al.  Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. , 2000, The Journal of urology.

[31]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Bahnson,et al.  DNA analysis of multiple synchronous renal cell carcinomas , 1990, Cancer.

[33]  L. Sobin,et al.  TNM staging of renal cell carcinoma , 1997, Cancer.

[34]  M. Stöckle,et al.  Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. , 1992, The Journal of urology.

[35]  J. Chmiel,et al.  Original Articles: Kidney Cancer: Renal Cell Carcinoma: Tumor Size, Stage and Survival , 1995 .

[36]  R. Motzer,et al.  Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma , 1995, Cancer.

[37]  R. Grimer,et al.  Radical surgery for the solitary bony metastasis from renal-cell carcinoma , 2000 .

[38]  J. Montie,et al.  Long-term results following partial nephrectomy for localized renal adenocarcinoma. , 1984, The Journal of urology.

[39]  R. Figlin,et al.  Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. , 2003, Urology.

[40]  M. Zelefsky,et al.  Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  J. Dekernion,et al.  Prognostic factors in metastatic renal carcinoma. , 1986, The Journal of urology.

[42]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[43]  R. Fisher,et al.  Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. , 2000, The cancer journal from Scientific American.

[44]  T. Ahlering,et al.  Experience with fossa recurrence of renal cell carcinoma. , 1992, The Journal of urology.

[45]  B. Wullich,et al.  Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue‐specific karyotype instability , 1993 .

[46]  M. Carini,et al.  Conservative surgical treatment of renal cell carcinoma: clinical experience and reappraisal of indications. , 1988, The Journal of urology.

[47]  P. Russo,et al.  Surgical resection of brain metastases from renal cell carcinoma in 50 patients. , 1996, Urology.

[48]  D. Decker,et al.  Brain metastases in patients with renal cell carcinoma: prognosis and treatment. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  D. Reede,et al.  Metastatic hypernephroma to the head and neck. , 1987, AJNR. American journal of neuroradiology.

[50]  M. Frydenberg,et al.  Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies. , 1994, The Journal of urology.

[51]  R. B. Smith,et al.  The natural history of metastatic renal cell carcinoma: a computer analysis. , 1978, The Journal of urology.

[52]  H. Zincke,et al.  Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. , 1990, The Journal of urology.

[53]  N. Yanagihara,et al.  Renal clear cell carcinoma metastatic to the nose and paranasal sinuses , 1982, The Laryngoscope.

[54]  S. Kent,et al.  Metastatic tumours in the maxillary sinus , 1985, The Journal of Laryngology & Otology.

[55]  B. Escudier,et al.  Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe. , 2000, The cancer journal from Scientific American.

[56]  M. Wirth,et al.  Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. , 2002, The Journal of urology.